AFT Pharmaceuticals Ltd. (AU:AFP) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
AFT Pharmaceuticals has reported record sales for the first half of 2024, driven by robust growth in the Australasian market despite economic challenges. While international sales faced temporary setbacks due to customer destocking and a doctors’ strike in South Korea, the company anticipates a strong recovery in the second half with new product launches. AFT is confident of maintaining its growth trajectory, forecasting an operating profit of $15 to $20 million by the end of March 2025.
For further insights into AU:AFP stock, check out TipRanks’ Stock Analysis page.